Press Releases

  • KGK Science Leads the Nutraceutical Industry into a New Era of Scientific and Statistical Concepts

    Tue, 29 Oct 2019

    A significant shift has taken place in scientific and statistical concepts in the nutraceutical space – a shift that Dr. Mal Evans, Chief Scientific Officer, KGK Science, and her team has been advocating for since 2014.

    View Full Article »

  • KGK Science Grows with the Addition of Dr. Corey Hilmas as Chief Regulatory Officer

    Mon, 07 Oct 2019

    Dr. Corey Hilmas brings substantial experience and industry credentials to KGK, allowing them to expand and bolster their regulatory services.

    View Full Article »

  • KGK Science Secures Cannabis Research License for a Clinical Trial Sponsored by New Age Nanotech

    Tue, 10 Sep 2019

    KGK Science Inc. has been issued a Cannabis Research License by Health Canada, Controlled Substances and Cannabis Branch, allowing the company to possess and administer cannabis for a Phase I human clinical trial.

    View Full Article »

  • KGK Science Applauds the Efforts of Congress to Begin Removing Regulatory Hurdles for CBD

    Wed, 26 Jun 2019

    KGK Science Welcomes This Bipartisan Amendment from the House. The Amendment Reflects Both the Intent and Spirit of the Dietary Supplement Health and Education Act of 1994, Which Gave Authority Over Supplements and Struck a Critical Balance Between...

    View Full Article »

  • KGK Science Joins the Natural Products Association as a New Board Member

    Mon, 01 Apr 2019

    The Time is Right for Us to Be a Leader at the Table in Those Board Discussions

    View Full Article »

  • KGK Science Inc. Announces Appointment of Stephen Holmes to CFO/COO and Ashley ten Haaf to...

    Mon, 10 Sep 2018

    London, Ontario, September 10, 2018 – Najla Guthrie, President & CEO, of KGK Science Inc. (

    View Full Article »

  • KGK Science Inc. Announces Appointment of Mal Evans Ph.D to Chief Scientific Officer

    Mon, 20 Aug 2018

    London, Ontario, August 20, 2018 – Najla Guthrie, President & CEO, of KGK Science Inc. (

    View Full Article »

  • ChromaDex Clinical Trial Studying NIAGEN® Well Underway, With Eight Additional Collaborative Human

    Wed, 20 Jul 2016

    IRVINE, Calif., July 20, 2016 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food ...

    View Full Article »

  • KGK Synergize Inc. To Run Half Marathon In Support Of Vitamin Angels

    Thu, 14 Nov 2013

    LONDON, ON, NOVEMBER 14, 2013 – KGK Synergize Inc., a contract research organization offering human clinical trials to the health nutrition industry, will be participating in the Rock ‘n’ Roll Las Vegas...

    View Full Article »

  • Next Pharmaceuticals Acquires Sytrinol

    Tue, 04 Jun 2013

    SALINAS, Calif., June 4, 2013—Next Pharmaceuticals acquired the distribution rights, patents, trademarks and scientific knowledge for Sytrinol from KGK Synergize....

    View Full Article »

  • KGK Synergize Inc. Welcomes Angela Kelly To Our Team!

    Fri, 01 Feb 2013

    LONDON, ON, FEBRUARY 1, 2013 – KGK Synergize Inc., a contract research organization offering human clinical trials to the health nutrition industry, is very pleased to welcome Angela Kelly to the KGK Synergize Inc....

    View Full Article »

  • KGK Synergize Inc. Announces Settlement Of Its Lawsuit With Sourceone Global Partners, Inc.

    Fri, 27 Jan 2012

    LONDON, ON, January 27, 2012– KGK Synergize Inc. (“KGK”), a product development and contract research organization for the health nutrition industry, announced today the settlement of the lawsuit agains...

    View Full Article »

Request a Quote

Fill in our simple online form and we will contact you back to discuss your requirements.

Request Quote

Twitter

Subscribe to our E-Newsletter

Sign up here to receive the latest news from KGK Science.

Subscribe To KGK Science